Thrivent Financial for Lutherans Acquires 111,169 Shares of iShares Biotechnology ETF $IBB

Thrivent Financial for Lutherans lifted its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 99.4% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 223,032 shares of the financial services provider’s stock after purchasing an additional 111,169 shares during the quarter. Thrivent Financial for Lutherans’ holdings in iShares Biotechnology ETF were worth $37,641,000 as of its most recent SEC filing.

Other hedge funds have also added to or reduced their stakes in the company. Allspring Global Investments Holdings LLC increased its stake in iShares Biotechnology ETF by 46,806.0% in the fourth quarter. Allspring Global Investments Holdings LLC now owns 46,906 shares of the financial services provider’s stock valued at $7,927,000 after acquiring an additional 46,806 shares during the last quarter. Aster Capital Management DIFC Ltd bought a new position in iShares Biotechnology ETF in the third quarter valued at approximately $1,907,000. Central Pacific Bank Trust Division increased its stake in iShares Biotechnology ETF by 296,500.0% in the fourth quarter. Central Pacific Bank Trust Division now owns 14,830 shares of the financial services provider’s stock valued at $2,503,000 after acquiring an additional 14,825 shares during the last quarter. Florin Court Capital LLP bought a new position in iShares Biotechnology ETF in the third quarter valued at approximately $11,116,000. Finally, Tudor Investment Corp ET AL bought a new position in iShares Biotechnology ETF in the third quarter valued at approximately $931,000. 62.45% of the stock is owned by institutional investors.

iShares Biotechnology ETF Price Performance

Shares of NASDAQ:IBB opened at $166.83 on Friday. The company’s 50 day simple moving average is $169.24 and its 200 day simple moving average is $169.57. iShares Biotechnology ETF has a 1 year low of $118.51 and a 1 year high of $179.64.

iShares Biotechnology ETF Cuts Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, March 20th. Investors of record on Tuesday, March 17th were paid a $0.1218 dividend. This represents a $0.49 dividend on an annualized basis and a yield of 0.3%. The ex-dividend date of this dividend was Tuesday, March 17th.

iShares Biotechnology ETF Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.